Semler Scientific Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $27.05
- Today's High:
- $28.1812
- Open Price:
- $27.46
- 52W Low:
- $19.12
- 52W High:
- $44.36
- Prev. Close:
- $27.03
- Volume:
- 84376
Company Statistics
- Market Cap.:
- $185.78 million
- Book Value:
- 9.728
- Revenue TTM:
- $64.65 million
- Operating Margin TTM:
- 33.28%
- Gross Profit TTM:
- $52.43 million
- Profit Margin:
- 27.44%
- Return on Assets TTM:
- 20.21%
- Return on Equity TTM:
- 30.6%
Company Profile
Semler Scientific Inc had its IPO on 2014-02-21 under the ticker symbol SMLR.
The company operates in the Healthcare sector and Medical Devices industry. Semler Scientific Inc has a staff strength of 127 employees.
Stock update
Shares of Semler Scientific Inc opened at $27.46 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $27.05 - $28.18, and closed at $28.06.
This is a +3.81% increase from the previous day's closing price.
A total volume of 84,376 shares were traded at the close of the day’s session.
In the last one week, shares of Semler Scientific Inc have increased by +2.33%.
Semler Scientific Inc's Key Ratios
Semler Scientific Inc has a market cap of $185.78 million, indicating a price to book ratio of 4.5951 and a price to sales ratio of 4.2347.
In the last 12-months Semler Scientific Inc’s revenue was $64.65 million with a gross profit of $52.43 million and an EBITDA of $21.69 million. The EBITDA ratio measures Semler Scientific Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Semler Scientific Inc’s operating margin was 33.28% while its return on assets stood at 20.21% with a return of equity of 30.6%.
In Q2, Semler Scientific Inc’s quarterly earnings growth was a positive 47.1% while revenue growth was a positive 25.5%.
Semler Scientific Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 12.1757
- PEG
- 0
Its diluted EPS in the last 12-months stands at $2.22 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Semler Scientific Inc’s profitability.
Semler Scientific Inc stock is trading at a EV to sales ratio of 3.5877 and a EV to EBITDA ratio of 12.2702. Its price to sales ratio in the trailing 12-months stood at 4.2347.
Semler Scientific Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $75.46 million
- Total Liabilities
- $10.08 million
- Operating Cash Flow
- $24.97 million
- Capital Expenditure
- $295000
- Dividend Payout Ratio
- 0%
Semler Scientific Inc ended 2024 with $75.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $75.46 million while shareholder equity stood at $65.26 million.
Semler Scientific Inc ended 2024 with $0 in deferred long-term liabilities, $10.08 million in other current liabilities, 7000.00 in common stock, $50.07 million in retained earnings and $0 in goodwill. Its cash balance stood at $39.50 million and cash and short-term investments were $51.83 million. The company’s total short-term debt was $8,243,000 while long-term debt stood at $0.
Semler Scientific Inc’s total current assets stands at $60.75 million while long-term investments were $5.78 million and short-term investments were $12.33 million. Its net receivables were $6.03 million compared to accounts payable of $509000.00 and inventory worth $476000.00.
In 2024, Semler Scientific Inc's operating cash flow was $24.97 million while its capital expenditure stood at $295000.
Comparatively, Semler Scientific Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $28.06
- 52-Week High
- $44.36
- 52-Week Low
- $19.12
- Analyst Target Price
- $65
Semler Scientific Inc stock is currently trading at $28.06 per share. It touched a 52-week high of $44.36 and a 52-week low of $44.36. Analysts tracking the stock have a 12-month average target price of $65.
Its 50-day moving average was $25.76 and 200-day moving average was $27.44 The short ratio stood at 5.68 indicating a short percent outstanding of 0%.
Around 2246.7% of the company’s stock are held by insiders while 5583.3% are held by institutions.
Frequently Asked Questions About Semler Scientific Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.